The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys

Psychopharmacology

Volumn 173, Issue 1, 2004, Pages 186-194

  Justinova, Zuzana ^a   Tanda, Gianluigi ^a   Munzar, Patrik ^a,b   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Alexza Pharmaceuticals   (United States)

Author keywords

9 Tetrahydrocannabinol (THC); Cocaine; Drug self administration; Marijuana; Naltrexone; Squirrel monkeys

Indexed keywords

CANNABIS; NALTREXONE; OPIATE ANTAGONIST; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DOSE RESPONSE; DRUG ABUSE; MALE; MONKEY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; TASK PERFORMANCE;

ANALGESICS, NON-NARCOTIC; ANESTHETICS, LOCAL; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SAIMIRI; SELF ADMINISTRATION; TETRAHYDROCANNABINOL;

EID: 2342593865     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1693-6     Document Type: Article

References (53)

1. Bain GT, Kornetsky C (1987) Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci 40:1119-1125
2. Beardsley PM, Balster RL, Harris LS (1986) Dependence on tetrahydrocannabinol in rhesus monkeys. J Pharmacol Exp Ther 239:311-319
3. Berrendero F, Maldonado R (2002) Involvement of the opioid system in the anxiolytic-like effects induced by delta(9)-tetrahydrocannabinol. Psychopharmacology 163:111-117
4. Bloom AS, Dewey WL (1978) A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse. Psychopharmacology 57:243-248
5. Braida D, Pozzi M, Cavallini R, Sala M (2001a) Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neuroscience 104:923-926
6. Braida D, Pozzi M, Parolaro D, Sala M (2001b) Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system. Eur J Pharmacol 413:227-234
7. Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL (1990) Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156-162
8. De Vries TJ, Homberg JR, Binnekade R, Raaso H, Schoffelmeer AN (2003) Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology 168:164-169
9. Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151-178
10. Emmerson PJ, Liu MR, Woods JH, Medzihradsky F (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271:1630-1637
11. Gardner EL, Paredes W, Smith D, Zukin RS (1989) Facilitation of brain stimulation reward by delta-9-tetrahydrocannabinol is mediated by an endogenous opioid mechanism. In: Cros J, Meunier J-C, Hamon M (eds) Progress in opioid research. Pergamon Press, New York, pp 671-674
12. Gewiss MV, Marley RJ, Thorndike EB, Goldberg SR, Schindler CW (1994) GABA receptor-linked chloride channels and the behavioral effects of naltrexone in rats. Pharmacol Biochem Behav 49:589-597
13. Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002) Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22:1146-1154
14. Goldberg SR (1973) Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey. J Pharmacol Exp Ther 186:18-30
15. Goldberg SR, Morse WH, Goldberg DM (1981) Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons. J Pharmacol Exp Ther 216:500-509
16. Greenwald MK, Stitzer ML (2000) Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend 59:261-275
17. Haney M, Bisaga A, Foltin RW (2003) Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology 166:77-85
18. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583
19. Hoffman AF, Lupica CR (2001) Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 85:72-83
20. Howlett AC (2002) The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69:619-631
21. Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003) Self-administration of delta(9)-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology 169:135-140
22. Kaymakcalan S, Ayhan IH, Tulunay FC (1977) Naloxone-induced or postwithdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats. Psychopharmacology 55:243-249
23. Killian AK, Bonese K, Schuster CR (1978) The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey. Drug Alcohol Depend 3:243-251
24. Kiyatkin EA, Brown PL (2003) Naloxone depresses cocaine self-administration and delays its initiation on the following day. Neuroreport 14:251-255
25. Ko MC, Butelman ER, Traynor JR, Woods JH (1998) Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys. J Pharmacol Exp Ther 285:518-526
26. Kreek MJ, LaForge KS, Butelman E (2002) Pharmacotherapy of addictions. Nat Rev Drug Discov 1:710-726
27. Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA (1998) Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain. Brain Res Mol Brain Res 55:126-132
28. Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20:287-294
29. Mello NK, Mendelson JH, Kuehnle JC, Sellers MS (1981) Operant analysis of human heroin self-administration and the effects of naltrexone. J Pharmacol Exp Ther 216:45-54
30. Mello NK, Mendelson JH, Bree MP, Lukas SE (1990) Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 254:926-939
31. Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del A, I, Villanua MA, Maldonado R, Koob GF, Rodriguez de Fonseca F (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344-5350
32. Olsen JL, Makhani M, Davis KH, Wall ME (1973) Preparation of 9-tetrahydrocannabinol for intravenous injection. J Pharm Pharmacol 25:344
33. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49:881-887
34. Reisine T, Law SF, Blake A, Tallent M (1996) Molecular mechanisms of opiate receptor coupling to G proteins and effector systems. Ann N Y Acad Sci 780:168-175
35. Rodriguez JJ, Mackie K, Pickel VM (2001) Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21:823-833
36. Sinclair JD (2001) Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol 36:2-10
37. Solinas M, Panlilio LV, Antoniou K, Pappas LA, Goldberg SR (2003a) The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J Pharmacol Exp Ther 306:93-102
38. Solinas M, Zangen A, Pappas LA, Goldberg SR (2003b) The subjective response to delta-9-tetrahydrocannabinol (THC) is modulated by activation of endogenous opioid systems in rats. Neuroscience 2003 abstracts (SfN 33rd Annual Meeting)
39. Svensson AI, Berntsson A, Eirefelt M, Söderpalm B (2000) Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes. J Neural Transm 107:261-270
40. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H (1994) Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151:1463-1467
41. Tanda G, Goldberg SR (2003) Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology 169:115-134
42. Tanda G, Pontieri FE, Di Chiara G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276:2048-2050
43. Tanda G, Munzar P, Goldberg SR (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3:1073-1074
44. Teal JJ, Holtzman SG (1980) Stimulus effects of morphine in the monkey: quantitative analysis of antagonism. Pharmacol Biochem Behav 12:587-593
45. Valverde O, Noble F, Beslot F, Dauge V, Fournie-Zaluski MC, Roques BP (2001) Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci 13:1816-1824
46. Vivian JA, Kishioka S, Butelman ER, Broadbear J, Lee KO, Woods JH (1998) Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A. J Pharmacol Exp Ther 286:697-703
47. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880
48. Wachtel SR, de Wit H (2000) Naltrexone does not block the subjective effects of oral delta(9)-tetrahydrocannabinol in humans. Drug Alcohol Depend 59:251-260
49. Welch SP, Stevens DL (1992) Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J Pharmacol Exp Ther 262:10-18
50. Williams KL, Woods JH (1998) Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcohol Clin Exp Res 22:1634-1639
51. Williams KL, Woods JH (1999) Naltrexone reduces ethanol- and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration. Alcohol Clin Exp Res 23:1462-1467
52. Williams KL, Winger G, Pakarinen ED, Woods JH (1998) Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology 139:53-61
53. Winger G, Skjoldager P, Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentanil-and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261:311-317